Drugs / 580299
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01381575 | Jun 2011 → Jun 2012 | human papilloma virus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01031069 | Oct 2010 → Jan 2016 | human papilloma virus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 580299 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01381575 ↗ |
| Modality | Vaccine | “HPV vaccine” NCT01381575 ↗ |
| Route | Intramuscular | “vaccine administered intramuscularly” NCT01381575 ↗ |